Dual ASX and NASDAQ smallcap Genetic Technologies (ASX:GTG) has announced its launch of a breast cancer imaging program across three US clinics in NY, Miami and Houston, Texas.
The program will integrate GTG’s “geneType” saliva-based and software-informed genomics prediction product – which it says can assess patient-by-patient genomic background datum to assess the probability risks that one may or may not develop cancer.
In the case of the program launched on Thursday, this will specifically address breast cancer, though, the company does offer similar products to men.
By using the company’s ‘geneType Breast Cancer Risk Assessment Test’ at imaging centres, the company believes “patients at higher risk of breast cancer can be easily identified during imaging appointments.”
All in all, the company’s tech is intended to fast-track those patients most at risk into triage. Part of this ability is due to the company’s inclusion of breast density data, according to GTG.
The company is also banking on customised patient data spurring enthusiasm for patient recipients, thus making them” more likely to adhere to recommended screening protocols,” according to GTG.
The company noted on Thursday that US breast cancer screening is predominately focused on women between the ages of 40 and 74, an addressable market of 68M individuals.
All this said, for a company on the NASDAQ, Genetic Technologies is relatively thinly traded down under.
Its shares were down nearly -8.6% in early lunchtime trades on Thursday following its announcement, based on some $54K worth of trading volume turnover. Compare that to leading financial stock CBA, whose trading volume turnover reflected $85M at the same time of day.
Interestingly, GTG’s market cap on the ASX is technically larger than that on the NASDAQ – A$18M down under vs. US$10M on the NASDAQ.
One HotCopper user on Thursday mused over how, exactly, this company receives so little attention – a stock that at one point also had some airtime on Channel 7’s nighttime programming.
GTG shares last traded at 16cps.